I have advanced expertise within health economics, clinical review, guideline development, pricing and reimbursement processes in several countries.Over 9 years of industry experience, leading a range of projects including HTA submissions, economic model development, survival modelling and meta-analysis, analyses of trial data, medical writing, clinical literature reviews, global value dossiers, and advisory boards.4+ years HTA experience as Senior Health Economist.2+ years’ experience as clinical assessor at the Danish Medicines Council (DMC) and Council for Expensive Medicines (RADS)Experienced in pricing and reimbursement from both a payer- and MAH perspective. Experienced negotiator, having both developed strategies, participated in and led multiple negotiations within various disease areas.Track record of representing clients at HTA stakeholder meetings.A core technical skill set covering health economic modelling, clinical evidence generation and systematic literature review.Experience in a wide range of health/disease areas (100+ indications)